2025-08-26 - Analysis Report
Okay, here's a report summarizing the provided information on Colgate-Palmolive Co (CL).

## Colgate-Palmolive Co (CL) Stock Analysis

**Ticker:** CL
**Company:** Colgate-Palmolive Co.
**Description:** A global consumer products company focusing on oral care, personal care, home care, and pet nutrition.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 11.60%
*   **VOO Cumulative Return:** 38.23%
*   **Spread:** -26.63%
*   **Spread Range:** Max: 38.3, Min: -26.5
*   **Relative Spread Position:** 2.8 (This indicates CL's underperformance relative to VOO is near its worst historical levels.)

**Analysis of Alpha, Beta, CAGR, and MDD:**

| Year       | CAGR    | MDD      | Alpha   | Beta    | Cap(B) |
|------------|---------|----------|---------|---------|--------|
| 2015-2017  | 13.0%   | 4.5%     | 13.0%   | 1.0     | 61.0   |
| 2016-2018  | -11.0%  | 65.2%    | -11.0%  | 1.0     | 48.1   |
| 2017-2019  | 7.0%    | 65.2%    | 7.0%    | 1.0     | 55.6   |
| 2018-2020  | 18.0%   | 65.2%    | 18.0%   | 1.0     | 69.1   |
| 2019-2021  | 30.0%   | 58.6%    | 29.0%   | 0.0     | 69.0   |
| 2020-2022  | 7.0%    | 69.0%    | 18.0%   | -0.0    | 63.7   |
| 2021-2023  | 6.0%    | 69.0%    | -4.0%   | -0.0    | 64.4   |
| 2022-2024  | 13.0%   | 69.0%    | -17.0%  | -0.0    | 73.5   |
| 2023-2025  | -2.0%   | 70.6%    | -46.0%  | 0.0     | 67.9   |

**Analysis:**

*   **Alpha:** The Alpha values are generally decreasing and negative in recent years, indicating underperformance relative to the market benchmark (S&P 500).
*   **Beta:** The Beta values are close to 0, suggesting a weak correlation with the market. This means CL's price movements are less influenced by overall market trends.
*   **CAGR:** The Compound Annual Growth Rate (CAGR) is inconsistent, with some periods showing positive growth and others showing negative growth.
*   **MDD:** The Maximum Drawdown (MDD) is relatively high in recent years, indicating significant potential losses from peak to trough during those periods.

### 2. Recent Stock Price Movement

*   **Current Price:** 84.06
*   **Previous Close:** 85.94
*   **Change:** -2.19
*   **5-Day Moving Average:** 85.64
*   **20-Day Moving Average:** 84.92
*   **60-Day Moving Average:** 88.16

**Analysis:**

The stock price has decreased recently. The current price is below the 5-day and 60-day moving averages but slightly below the 20-day moving average, suggesting a short-term downward trend. The negative change of -2.19 indicates a notable price decrease in the most recent trading session.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.32 (Low Risk)
*   **RSI:** 54.56
*   **PPO:** 0.25
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1209 shares - Safe (OverSold Boost) - MRI:0.32)
*   **Recent (20-day) Relative Spread Change:** 1.4 (+) - Short-term increase
*   **Expected Return:** 656.1% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** Indicates low market risk.
*   **RSI:** The RSI is at 54.56, suggesting neutral momentum. It's neither overbought nor oversold.
*   **PPO:** The PPO at 0.25 indicates a slight positive trend in price momentum.
*   **Hybrid Signal:** The "Buy" signal with 100% cash allocation indicates a potentially favorable entry point.
*   **Delta_Previous_Relative_Divergence**: 1.4 (+): A positive value suggests short-term upward trend
*   **Price Change:** The significant negative change from the previous close suggests a notable downward movement in the stock price, potentially reflecting recent news or market sentiment.

### 4. Recent News & Significant Events

*   **[2025-08-25]:** Business developments, regulatory changes, or market events.
*   **[2025-08-26]:** Analyst discussions on performance, industry trends, and global economic factors.
*   **[2025-08-24]:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-08-22]:** Market experts highlighting risks and opportunities, advising monitoring of news and announcements.

**Analysis:**

Recent news indicates potential volatility and significant events impacting Colgate-Palmolive. Investors should closely monitor news and analyst reports for further insights.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-08-01 | 0.92 | 5.11 B$  |
| 2025-04-25 | 0.85 | 4.91 B$  |
| 2024-10-25 | 0.9  | 5.03 B$  |
| 2024-07-26 | 0.89 | 5.06 B$  |
| 2025-08-01 | 0.89 | 5.06 B$  |

**Analysis:**

The EPS (Earnings Per Share) has shown slight fluctuations over the last few quarters. The revenue has been relatively stable, around $5 billion. There is some duplication of data, the last row is a repeat of the first.

### 6. Financial Information

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $5.11B  | 60.06%        |
| 2025-03-31 | $4.91B  | 60.82%        |
| 2024-12-31 | $4.95B  | 60.30%        |
| 2024-09-30 | $5.03B  | 61.08%        |
| 2024-06-30 | $5.06B  | 60.62%        |

| Quarter    | Equity  | ROE       |
|------------|---------|-----------|
| 2025-06-30 | $0.70B  | 105.84%   |
| 2025-03-31 | $0.36B  | 190.08%   |
| 2024-12-31 | $0.21B  | 348.58%   |
| 2024-09-30 | $0.43B  | 169.43%   |
| 2024-06-30 | $0.12B  | 594.31%   |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue is relatively stable, and the profit margin remains consistently high, indicating strong profitability.
*   **Equity and ROE:** The Equity has fluctuated, and the Return on Equity (ROE) is extremely high, which might be due to the relatively low equity values. A very high ROE warrants further investigation to understand the underlying reasons.

### 7. 종합적인 분석

**Summary:**

Colgate-Palmolive (CL) is currently underperforming the S&P 500, with its underperformance near historical lows. Technical indicators suggest a neutral to slightly positive short-term outlook. The MRI indicates low market risk, and the Hybrid Signal suggests a potential buying opportunity. However, recent price volatility and news warrant caution.

**Key Points:**

*   **Underperformance:** CL has significantly underperformed the S&P 500.
*   **Financial Stability:** Strong and stable revenue and profit margins. The recent high ROE values are noteworthy and require further analysis.
*   **Technical Signals:** Mixed signals with a recent price drop but potential oversold conditions.
*   **Risk:** The recent volatility and potential market-moving events, which needs to be monitored.
*   **Recommendation (Based on Data):** While the long-term expected return is very high, the current underperformance and recent price action require careful consideration. Given the Hybrid Signal and low MRI, a small, strategic buy may be considered, but with close monitoring of news and market conditions. Further investigation into the high ROE is essential.
